Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

ClinicalTrials.gov ID: NCT00637247

Public ClinicalTrials.gov record NCT00637247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Amplimexon® Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy Naïve Pancreatic Adenocarcinoma (Stage IV)

Study identification

NCT ID
NCT00637247
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AmpliMed Corporation
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

  • imexon in combination with gemcitabine Drug
  • imexon placebo + gemcitabine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Apr 30, 2010
Completion
May 31, 2010
Last update posted
Mar 19, 2019

2008 – 2010

United States locations

U.S. sites
48
U.S. states
22
U.S. cities
44
Facility City State ZIP Site status
Birmingham Hematology and Oncology- US Oncology Birmingham Alabama 35205
AZ Onc Associates D.B.A. Hematology Oncology- US Oncology Tucson Arizona 85704
Arizona Clinical Research Center Tucson Arizona 85715
Rocky Mountain Cancer Center- US Oncology Denver Colorado 80218
Ocala Oncology Center- US Oncology Ocala Florida 34471
Cancer Centers of Florida- US Oncology Orlando Florida 34761
Peachtree Hematology and Oncology Consultants Atlanta Georgia 30309
Hematology Oncology Associates of Illinois- US Oncology Chicago Illinois 60611
Cancer Care & Hematolog Specialists of Chicagoland- US Oncology Niles Illinois 60714
Central Indiana Cancer Centers- US Oncology Indianapolis Indiana 46227
Northern Indiana Cancer Research Consortium South Bend Indiana 46601
Hope Center- US Oncology Terre Haute Indiana 47802
University of Kentucky, Hematology/Oncology/BMT Clinical Research Lexington Kentucky 40536-0093
Lahey Clinic Burlington Massachusetts 01805
University of Michigan Ann Arbor Michigan 48109
University of Minnesota Minneapolis Minnesota 55455
Kansas City Cancer Center, LLC- US Oncology Kansas City Missouri 64131
Comprehensive Cancer Centers of Nevada- US Oncology Las Vegas Nevada 89169
Hunterdon Regional Cancer Center Flemington New Jersey 08822
Hematology Oncology Associates Mount Holly New Jersey 08060
Hematology Oncology Associates Albuquerque New Mexico 87106
University of New Mexico Albuquerque New Mexico 87131
University of New Mexico Cancer Center South Las Cruces New Mexico 88011
New Mexico Cancer Care Associates- US Oncology Santa Fe New Mexico 87505
Roswell Park Cancer Institute Buffalo New York 14263
Cancer Center of North Carolina- US Oncology Raleigh North Carolina 27607
Medical Onc Assoc of Wyoming Valley, PC- US Oncology Kingston Pennsylvania 18704
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232
Pottstown Memorial Medical Center Pottstown Pennsylvania 19464
Associates in Hematology-Oncology P.C. US Oncology Upland Pennsylvania 19013
Reading Hospital Regional Medical Center West Reading Pennsylvania 19611
Sanford Clinic Sioux Falls South Dakota 57104
Texas Oncology - Amarillo- US Oncology Amarillo Texas 79106
Mamie Mcfaddin Ward Cancer Center, Texas Oncology- US Oncology Beaumont Texas 77702
Texas Oncology P.A.- Bedford- US Oncology Bedford Texas 76022
Texas Cancer Center at Medical City- US Oncology Dallas Texas 75230
Texas Oncology P.A. - Dallas- US Oncology Dallas Texas 75231
Methodist Charlton Cancer Center - Texas Oncology- US Oncology Dallas Texas 75237
Texas Oncology - Odessa- US Oncology Odessa Texas 79761
Scott and White Hospital and Clinics Temple Texas 76508
Texas Oncology Cancer Care and Research Center- US Oncology Waco Texas 76712
Texoma Cancer Center- US Oncology Wichita Falls Texas 76310
Virginia Oncology Associates- US Oncology Norfolk Virginia 23502
Onc & Hematology Assoc. of Southern VA, Inc D.B.A. - US Oncology Salem Virginia 24153
Swedish Cancer Institute Seattle Washington 98104
Cancer Care Northwest- US Oncology Spokane Washington 99202
Northwest Cancer Specialists- US Oncology Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00637247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00637247 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →